Fortimicin KR1

2,3,4,6-tetra-O-acetyl-N-benzoyl-β-D-mannopyranosylamine

allyl O-(3,4,6-tri-O-benzyl-β-D-mannopyranosyl)-(1[*]4)-O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-β-D-glucopyranosyl)-(1[*]4)-2-acetamido-3,6-di-O-(2-butenyl)-2-deoxy-β-D-glucopyranoside

(3S,4S,6S)-2-(hydroxymethyl)-6-prop-2-enoxyoxane-3,4,5-triol

DL-(1,2,3,5/4)-5-acethoxymethyl-1,2,3,4-tetra-O-acetyl-1,2,3,4-cyclohexanetetrol

Butanedioic acid, 2,3-dihydroxy-2,3-dimethyl-

3-O-(4-O-β-D-mannopyranosyl-α-L-rhamnopyranosyl)-α-D-galactopyranose

α-D-Mannopyranoside, α-D-mannopyranosyl

β-D-Xylopyranoside, methyl 2,3-di-O-methyl-4-O-(2,3,4-tri-O-methyl-β-D-xylopyranosyl)-

Methyl 2-O,4-O-dimethyl-3-O-(2-O,3-O,4-O-trimethyl-β-D-xylopyranosyl)-β-D-xylopyranoside